Press release
Atherosclerosis Drugs Market 2024-2033: Trends, Size, Share Analysis, and Comprehensive Growth Forecast
Atherosclerosis Drugs Global Market Report 2024
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=12621&type=smp
According to The Business Research Company's, The atherosclerosis drugs market size has grown steadily in recent years. It will grow from $48.72 billion in 2023 to $50.5 billion in 2024 at a compound annual growth rate (CAGR) of 3.6%. The growth in the historic period can be attributed to cholesterol management, blood pressure control, smoking cessation programs, research and development, diagnostic advancements.
The atherosclerosis drugs market size is expected to see steady growth in the next few years. It will grow to $57.03 billion in 2028 at a compound annual growth rate (CAGR) of 3.1%. The growth in the forecast period can be attributed to emerging therapies, precision medicine, immunotherapy and inflammation, innovations in lipid management, regulatory support. Major trends in the forecast period include biologic therapies, gene editing and gene therapy, combination therapies, personalized treatment approaches, telemedicine and remote monitoring.
Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/atherosclerosis-drugs-global-market-report
Market Drivers and Trends:
The prevalence of cardiovascular diseases is expected to propel the growth of the atherosclerosis drug market going forward. Cardiovascular diseases refer to all the diseases that can affect the heart and blood vessels, and atherosclerosis refers to the buildup of fats, cholesterol, and other substances on the artery walls of a person. Atherosclerosis is a condition characterized by the buildup of plaque inside the arteries that causes cardiovascular diseases such as coronary heart disease and stroke. Atherosclerosis drugs are used to treat cardiovascular diseases by reducing the risk of complications and managing underlying conditions such as increased cholesterol levels and blood clot formation. For instance, in March 2022, according to a report published by The Office for National Statistics, a UK-based government department, between 2020 and 2021, 19,440 to 20,061 people died due to heart attacks. Further, in May 2023, the Centers for Disease Control and Prevention., a US-based national public health agency, reported that in the US, 1 in 20 adults aged 20 and older have cardiovascular diseases, and 695,000 people were suffering from cardiovascular diseases in 2021, and 375,476 people died with cardiovascular diseases that same year. Therefore, the prevalence of cardiovascular diseases will drive the atherosclerosis drug market.
Product innovation is a key trend gaining popularity in the atherosclerosis drugs market going forward. Major companies operating in the atherosclerosis drugs market are developing innovative drugs and getting approvals to sustain their position in the market. For instance, in December 2021, Novartis AG, a Switzerland-based pharmaceutical company, received the US Food and Drug Administration (FDA) approval for Leqvio (inclisiran), a first-of-its-kind siRNA to lower cholesterol and treat people with atherosclerotic cardiovascular disease. This new drug is in the form of subcutaneous injection and reduces the amount of LDL (low-density lipoproteins) cholesterol in the bloodstream for the treatment of adults with clinical atherosclerotic cardiovascular disease. It provides a new option for patients who are not able to achieve their LDL cholesterol goals with other therapies.
Key Benefits for Stakeholders:
• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.
Major Key Players of the Market:
Johnson And Johnson Private Limited, Pfizer Inc., F. Hoffmann-La Roche AG, AbbVie Inc., Bayer AG, Janssen Pharmaceuticals Inc., Novartis AG, Merck And Co.Inc., Sanofi S.A., AstraZeneca plc, Abbott Laboratories, GSK plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Novo Nordisk A/S, Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Otsuka Holdings Co. Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Lupin Limited, Alnylam Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Amarin Corporation plc, Esperion Therapeutics Inc., Kowa Pharmaceuticals America Inc., Anthera Pharmaceuticals Inc
Atherosclerosis Drugs Market 2024 Key Insights:
• The atherosclerosis drugs market size is expected to see steady growth in the next few years. It will grow to $57.03 billion in 2028 at a compound annual growth rate (CAGR) of 3.1%.
• Atherosclerosis Drugs Rise With The Surge In Cardiovascular Diseases
• Atherosclerosis Drugs Market Embraces Product Innovation
• North America was the largest region in the atherosclerosis drugs market in 2023
We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=12621&type=smp
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Atherosclerosis Drugs Market 2024-2033: Trends, Size, Share Analysis, and Comprehensive Growth Forecast here
News-ID: 3765732 • Views: …
More Releases from The Business research company
Evolving Market Trends In The Integrated Geophysical Services Industry: Enhancin …
The Integrated Geophysical Services Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Integrated Geophysical Services Market Size During the Forecast Period?
The integrated geophysical services market has experienced consistent growth in recent years, expected to rise from $2.35 billion in 2024 to…
Global HR Advisory Services Market: Key Trends, Market Share, Growth Drivers, An …
The HR advisory services market report describes and explains the HR advisory services market and covers 2019-2024, termed the historic period, and 2024-2029, 2034F termed the forecast period. The report evaluates the market across each region and for the major economies within each region.
The global HR advisory services market reached a value of nearly $155.74 billion in 2024, having grown at a compound annual growth rate (CAGR) of 4.22% since…
High Voltage Aluminium Electrolytic Capacitors Global Market Report 2025: Size, …
The high voltage aluminum electrolytic capacitors report describes and explains the high voltage aluminum electrolytic capacitors market and covers 2019-2024, termed the historic period, and 2024-2029, 2034F termed the forecast period. The report evaluates the market across each region and for the major economies within each region.
The global high voltage aluminum electrolytic capacitors market reached a value of nearly $4.10301 billion in 2024, having grown at a compound annual growth…
Global Vertical Market Software Market: Key Trends, Market Share, Growth Drivers …
The vertical market software report describes and explains the vertical market software market and covers 2019-2024, termed the historic period, and 2024-2029, 2034F termed the forecast period. The report evaluates the market across each region and for the major economies within each region.
The global vertical market software market reached a value of nearly $152.61027 billion in 2024, having grown at a compound annual growth rate (CAGR) of 12.11% since 2019.…
More Releases for Atherosclerosis
Leading Growth Driver in the Atherosclerosis Drugs Market in 2025: Atheroscleros …
Which drivers are expected to have the greatest impact on the over the atherosclerosis drugs market's growth?
The anticipated growth of the atherosclerosis drug market is likely due to the increased prevalence of cardiovascular diseases. These ailments usually impact the heart and blood vessels, and atherosclerosis, a condition arising from the accumulation of fats, cholesterol, and other substances on one's artery walls, is usually responsible. Key complications of atherosclerosis include coronary…
Atherosclerosis Therapeutics Market Projected to Show Strong Growth
The "Atherosclerosis Therapeutics Market" intelligence report, just published by USD Analytics Market, covers a micro-level study of important market niches, product offers, and sales channels. to determine market size, potential, growth trends, and competitive environment, the Atherosclerosis Therapeutics Market provides dynamic views. Both primary and secondary sources of data were used to generate the research, which has both qualitative and quantitative depth. Several of the major figures the study featured…
Atherosclerosis Drugs Market Size 2024 to 2031.
Market Overview and Report Coverage
Atherosclerosis is a condition characterized by the buildup of plaque in the arteries, leading to restricted blood flow and an increased risk of heart attack or stroke. Atherosclerosis drugs are medications used to manage the symptoms and complications of this condition.
The Atherosclerosis Drugs Market is expected to grow at a CAGR of 4.00% during the forecasted period. The increasing prevalence of lifestyle-related diseases such…
Atherosclerosis Therapeutics Market: Competitive Dynamics & Global Outlook 2024
LP INFORMATION offers a latest published report on Atherosclerosis Therapeutics Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report.
According to this study, over the next five years the Atherosclerosis Therapeutics market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular,…
Atherosclerosis Therapeutics Market: Competitive Dynamics & Global Outlook 2025
Market Research Report Store offers a latest published report on Atherosclerosis Therapeutics Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report.
This report focuses on the key global Atherosclerosis Therapeutics players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Atherosclerosis Therapeutics with respect to individual growth…
Atherosclerosis Market Revenue and Value Chain 2016-2026
Atherosclerosis is the narrowing of the vein as a result of plaque build-up. Atherosclerosis is a particular kind of arteriosclerosis (stiffening or solidifying of the artery walls). The illness disturbs the stream of blood around the body, posturing genuine cardiovascular entanglements. Atherosclerosis begins when the endothelium gets to be harmed, permitting LDL cholesterol to aggregate in the artery wall. The body sends macrophage white platelets to tidy up the cholesterol.…
